SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-15-001563
Filing Date
2015-03-03
Accepted
2015-03-03 13:53:36
Documents
12
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2223270z10-k.htm 10-K 1234816
2 EX-23.1 a2223270zex-23_1.htm EX-23.1 4806
3 EX-31.1 a2223270zex-31_1.htm EX-31.1 7935
4 EX-31.2 a2223270zex-31_2.htm EX-31.2 7910
5 EX-32.1 a2223270zex-32_1.htm EX-32.1 5282
12 G468503.JPG g468503.jpg GRAPHIC 36324
  Complete submission text file 0001047469-15-001563.txt   11759511

Data Files

Seq Description Document Type Size
6 EX-101.INS rigl-20141231.xml EX-101.INS 2323179
7 EX-101.SCH rigl-20141231.xsd EX-101.SCH 55230
8 EX-101.CAL rigl-20141231_cal.xml EX-101.CAL 51396
9 EX-101.LAB rigl-20141231_lab.xml EX-101.LAB 556442
10 EX-101.PRE rigl-20141231_pre.xml EX-101.PRE 383330
11 EX-101.DEF rigl-20141231_def.xml EX-101.DEF 194369
Mailing Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 1180 VETERANS BOULEVARD SOUTH SAN FRANCISCO CA 94080
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

IRS No.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-29889 | Film No.: 15668186
SIC: 2834 Pharmaceutical Preparations